Kevin Fitzpatrick

Kevin Fitzpatrick currently serves as President and CEO of Enforme Interactive, a software and services company focused on healthcare related professional associations.  Prior to Enforme, he served as senior advisor to PAIGE.AI a computational pathology start-up associated with Memorial Sloan Kettering Cancer Center.   

From 2015-2018, he served as the first CEO of CancerLinQ™, a rapid learning system for oncology and a subsidiary of the American Society of Clinical Oncology. (ASCO) There he led CancerLinQ through its rapid nationwide adoption and initial strategic transaction.

Prior to CancerLinQ™, he served for seven years as the Executive Vice President and Chief Innovation Officer of the American College of Cardiology (ACC), where he jointly led the organization’s overall operational and strategic planning.

Prior to joining the ACC, Mr. Fitzpatrick was Vice President of Business Development for the medical publisher, Lippincott Williams & Wilkins.  Earlier in his career he served as Managing Director of The Duke/Hewlett Packard Center for Outcomes Research and Director of the Trauma Research Laboratory at Duke University Medical Center. He received the Smithsonian Institution/Computer World Healthcare Computing Innovation Award in 1996.

At the American College of Cardiology, Mr. Fitzpatrick was instrumental in the creation and implementation of the Diabetes Collaborative Registry (DCR).  The DCR was the first global, cross-specialty clinical diabetes registry designed to track and improve the quality of diabetes and metabolic care across the primary and specialty care continuum. In addition, he was very involved in the growth and development of ACC’s PINNACLE Registry®, cardiology's largest outpatient quality improvement registry, capturing data on coronary artery disease, hypertension, heart failure and atrial fibrillation.